Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Varian Medical Systems	Sonova	Masimo	Getinge	LivaNova
Symbol	NYSE:VAR	OTCMKTS:SONVY	NASDAQ:MASI	OTCMKTS:GNGBY	NASDAQ:LIVN
Price Information
Current Price	$177.07	$57.77	$245.74	$30.56	$81.34
52 Week Range	Hold	Hold	Buy	Buy	Hold
MarketRank™
Overall Score	1.3	0.9	1.6	0.6	1.5
Analysis Score	0.8	0.0	2.4	0.0	1.2
Community Score	2.6	1.9	2.6	2.3	2.7
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	0.0	1.7	0.0	1.7
Earnings & Valuation Score	1.3	2.5	1.3	0.6	1.9
Analyst Ratings
Consensus Recommendation	Hold	Hold	Buy	Buy	Hold
Consensus Price Target	$159.36	N/A	$272.20	N/A	$69.33
% Upside from Price Target	-10.00% downside	N/A	10.77% upside	N/A	-14.76% downside
Trade Information
Market Cap	$16.26 billion	$18.60 billion	$13.58 billion	$7.77 billion	$3.96 billion
Beta	1.06	0.7	0.87	0.83	0.8
Average Volume	746,780	21,845	329,233	1,857	494,533
Sales & Book Value
Annual Revenue	$3.17 billion	$2.96 billion	$937.84 million	$2.81 billion	$1.08 billion
Price / Sales	5.13	6.29	14.48	2.76	3.65
Cashflow	$5.07 per share	$2.41 per share	$3.46 per share	$2.08 per share	$6.95 per share
Price / Cash	34.94	23.93	71.04	14.69	11.70
Book Value	$22.92 per share	$6.35 per share	$21.90 per share	$8.15 per share	$28.59 per share
Price / Book	7.73	9.10	11.22	3.75	2.85
Profitability
Net Income	$269.20 million	$489.96 million	$196.22 million	$129.29 million	$-155,180,000.00
EPS	$3.91	$1.49	$3.22	N/A	$3.08
Trailing P/E Ratio	60.43	38.77	63.83	25.25	N/A
Forward P/E Ratio	30.11	28.32	65.71	∞	44.21
P/E Growth	N/A	N/A	3.79	N/A	N/A
Net Margins	8.50%	N/A	20.30%	10.51%	-21.88%
Return on Equity (ROE)	18.45%	N/A	15.75%	17.30%	5.55%
Return on Assets (ROA)	8.08%	N/A	13.12%	7.90%	3.07%
Dividend
Annual Payout	N/A	N/A	N/A	$0.11	N/A
Dividend Yield	N/A	N/A	N/A	0.36%	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	0.69%	N/A	0.50%	0.47%
Current Ratio	1.40%	2.57%	4.98%	1.79%	2.39%
Quick Ratio	1.13%	2.26%	4.10%	1.25%	1.76%
Ownership Information
Institutional Ownership Percentage	86.96%	1.12%	81.64%	0.02%	89.10%
Insider Ownership Percentage	0.78%	N/A	11.50%	N/A	0.48%
Miscellaneous
Employees	10,000	14,349	2,000	10,497	4,000
Shares Outstanding	91.84 million	321.99 million	55.27 million	254.15 million	48.66 million
Next Earnings Date	5/3/2021 (Estimated)	5/18/2021 (Estimated)	4/27/2021 (Confirmed)	4/20/2021 (Estimated)	4/28/2021 (Confirmed)
Optionable	Optionable	Not Optionable	Optionable	Not Optionable	Optionable

Source	Headline
	Global Oxygenator Market 2021 Top Key Players – Medtronic, Terumo, Sorin Group (LivaNova), EUROSETS Srl, Chalice Medical Ltd - Los Hijos de la Malinche loshijosdelamalinche.com - April 15 at 8:15 AM
	Global Epilepsy Market 2021 Overview, Opportunities, In-Depth Analysis by 2025 : LivaNova, GW Pharmaceuticals, Johnson & Johnson Services, GlaxoSmithKline PLC, Pfizer, Eisai, NeuroPace - Los Hijos de la Malinche loshijosdelamalinche.com - April 15 at 3:15 AM
	Is LIVN Stock A Buy or Sell? - Yahoo Finance finance.yahoo.com - April 14 at 10:14 PM
	LivaNova (NASDAQ:LIVN) Reaches New 1-Year High After Analyst Upgrade americanbankingnews.com - April 14 at 12:22 PM
	Is LIVN Stock A Buy or Sell? finance.yahoo.com - April 14 at 12:14 PM
	3rd Cir. Reinstates LivaNova 3T Heater-Cooler System Action - HarrisMartin Publishing harrismartin.com - April 13 at 4:12 PM
	Piper Sandler Boosts LivaNova (NASDAQ:LIVN) Price Target to $92.00 americanbankingnews.com - April 13 at 9:16 AM
	LivaNova (NASDAQ:LIVN) Given New $92.00 Price Target at Piper Sandler marketbeat.com - April 13 at 7:29 AM
	$232.08 Million in Sales Expected for LivaNova PLC (NASDAQ:LIVN) This Quarter americanbankingnews.com - April 13 at 3:16 AM
	LivaNova PLC (LIVN) Stock: What Does the Chart Say Monday? - InvestorsObserver investorsobserver.com - April 12 at 5:49 PM
	Heater-Cooler suit against LivaNova revived - Mass Device massdevice.com - April 12 at 12:49 PM
	Zacks: Analysts Expect LivaNova PLC (NASDAQ:LIVN) to Post $0.15 Earnings Per Share americanbankingnews.com - April 11 at 2:12 PM
	Global Ventricular Assist Device Market Expected To Reach $ 2498.37 Million Growth By 2026\|\|Evaheart, Inc., Jarvik Heart, Inc., Medtronic, Terumo Corporation, ReliantHeart Inc., Calon Cardio, LivaNova PLC – ROUGH Magazine - ROUGH Magazine rough.asia - April 9 at 7:50 PM
	3rd Circ. Revives LivaNova Bacteria Exposure Suit - Law360 law360.com - April 9 at 7:50 PM
	LivaNova Heater-Cooler Patient Gets Infection Suit Reinstated - Bloomberg Law news.bloomberglaw.com - April 9 at 2:50 PM
	Global Epilepsy Market 2021 SWOT Analysis – LivaNova, GW Pharmaceuticals, Johnson & Johnson Services, GlaxoSmithKline PLC, Pfizer, Eisai – ROUGH Magazine - ROUGH Magazine rough.asia - April 7 at 2:19 PM
	Congestive Heart Failure Treatment Device Market 2021 Outlook By Micromed AS, LivaNova PLC, ABIOMED – The Market Eagle - The Market Eagle themarketeagle.com - April 7 at 2:19 PM
	Global Aortic Heart Valve Market 2021 Key Drivers – Edwards Lifesciences, Medtronic, Abbott, Livanova – ROUGH Magazine - ROUGH Magazine rough.asia - April 7 at 9:18 AM
	Global Double Roller Pump Artificial Heart Lung Machine Market 2021 Industry Dynamics – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH Magazine rough.asia - April 7 at 9:18 AM
	Global Single Roller Pump Artificial Heart Lung Machine Market 2021 Key Drivers – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH Magazine rough.asia - April 7 at 9:18 AM
	Global Blood Pump-Gas Exchange System Market 2021 Key Drivers – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH Magazine rough.asia - April 7 at 9:18 AM
	Global Seizure Detection Devices Market Things to Focus on to Ensure Long-term Success \| Medtronic PLC, - Global Banking And Finance Review globalbankingandfinance.com - April 6 at 12:56 PM
	Global Artificial Cardiopulmonary Machine Market 2021 SWOT Analysis – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH Magazine rough.asia - April 6 at 2:56 AM
	Global Percutaneous Mechanical Circulatory Support Devices Market Ongoing Analysis 2021 – Medtronic, Abbott Laboratories, LivaNova – ROUGH Magazine - ROUGH Magazine rough.asia - April 5 at 4:35 PM
	Global Long-term Mechanical Circulatory Support Market Ongoing Analysis 2021 – Abbott Laboratories, LivaNova, Nipro Corporation – ROUGH Magazine - ROUGH Magazine rough.asia - April 5 at 11:35 AM
	Cardiac Monitoring Devices Market New Business Experts Ideas By Biotronik, Livanova, Biotelemetry, Schiller, iRhythm Technologies - Industry Today industrytoday.co.uk - April 5 at 6:35 AM

Date	Company	Brokerage	Action
3/1/2021	Varian Medical Systems	UBS Group	Downgrade
12/7/2020	Varian Medical Systems	Jefferies Financial Group	Downgrade
10/28/2020	Varian Medical Systems	Barrington Research	Downgrade
10/28/2020	Varian Medical Systems	Robert W. Baird	Downgrade
8/10/2020	Varian Medical Systems	BTIG Research	Downgrade
8/2/2020	Varian Medical Systems	Piper Sandler	Downgrade
3/24/2021	Sonova	JPMorgan Chase & Co.	Reiterated Rating
2/18/2021	Sonova	Exane BNP Paribas	Upgrade
12/9/2020	Sonova	Morgan Stanley	Reiterated Rating
11/23/2020	Sonova	Berenberg Bank	Reiterated Rating
11/17/2020	Sonova	Credit Suisse Group	Reiterated Rating
10/8/2020	Sonova	Citigroup	Initiated Coverage
9/29/2020	Sonova	Deutsche Bank Aktiengesellschaft	Reiterated Rating
10/31/2019	Sonova	The Goldman Sachs Group	Downgrade
1/29/2021	Masimo	Raymond James	Boost Price Target
10/28/2020	Masimo	Stifel Nicolaus	Boost Price Target
10/6/2020	Masimo	Needham & Company LLC	Reiterated Rating
12/17/2019	Masimo	Piper Jaffray Companies	Reiterated Rating
4/13/2021	Getinge	DNB Markets	Upgrade
3/11/2021	Getinge	SEB Equity Research	Upgrade
3/11/2021	Getinge	SEB Equities	Upgrade
9/9/2020	Getinge	Bank of America	Initiated Coverage
4/30/2020	LivaNova	Canaccord Genuity	Lower Price Target

(Data available from 4/17/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources